Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer-Reference-Cited by-同舟云学术

Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer

Published:2020-03 Issue: Volume:153 Page:104683
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Deepak K.G.K.,Vempati Rahul,Nagaraju Ganji Purnachandra,Dasari Venkata Ramesh,S. Nagini,Rao D.N.,Malla Rama Rao

Funder

DST-EMR

CSIR

(RRM), New Delhi, India

Publisher

Elsevier BV

Subject

Pharmacology

Reference255 articles.

1. Understanding and treating triple-negative breast cancer;Anders;Oncology (Williston Park, N.Y.),2008

2. Alarming burden of triple-negative breast Cancer in India;Thakur;Clin. Breast Cancer,2018

3. Impact of breast cancer subtypes on prognosis of women with operable invasive breast cancer: a population-based study using SEER database;Hwang;Clin. Cancer Res.,2019

4. Triple-negative breast cancer and the potential for targeted therapy;Jhan;Pharmacogenomics,2017

5. Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer;Silver;J. Clin. Oncol.,2010

Cited by 350 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolving immunotherapeutic solutions for triple-negative breast carcinoma;Cancer Treatment Reviews;2024-11

2. Targeting overexpressed surface proteins: A new strategy to manage the recalcitrant triple-negative breast cancer;European Journal of Pharmacology;2024-10

3. ALG3 predicts poor prognosis and increases resistance to anti-PD-1 therapy through modulating PD-L1 N-link glycosylation in TNBC;International Immunopharmacology;2024-10

4. SPI1-mediated transcriptional activation of CEP55 promotes the malignant growth of triple-negative breast cancer and M2 macrophage polarization;Pathology - Research and Practice;2024-10

5. A self-targeting MOFs nanoplatform for treating metastatic triple-negative breast cancer through tumor microenvironment remodeling and chemotherapy potentiation;International Journal of Pharmaceutics;2024-10